Pyrazolo[1,5a]pyrimidine derivatives as modulators of IRAK4
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- F HOFFMANN LA ROCHE & CO AG
- Publication Date
- 2021-11-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] Cross References to Related Applications
[0002] This application claims U.S. Provisional Application No. 62 / 271,171, filed December 22, 2015, U.S. Provisional Application No. 62 / 279,459, filed January 15, 2016, and U.S. Provisional Application No. 62 / 279,459, filed September 22, 2016. 62 / 398,341 interests.
[0003] field of invention
[0004] The present invention relates to compounds useful for inhibiting interleukin-1 receptor-associated kinase 4 (IRAK4).
[0005] Background of the invention
[0006] Cell surface receptors containing TIR-domain (Toll-Interleukin 1 receptor-domain) such as Toll-like receptor (TLR) and IL-1 and IL-18 receptors play a key role in innate immunity, And it is related to the pathogenesis of autoimmunity. For example, TLRs recognize pathogenic or endogenous ligands and provide the necessary signals for dendritic cell maturation and antigen presentation to T cells. Similarly, proteins that mediate signaling by these receptors have also be...